A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Safety And Efficacy Of PF-04965842 In Subjects With Moderate To Severe Psoriasis
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2016
At a glance
- Drugs PF 4965842 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Jun 2017 Biomarkers information updated
- 08 Oct 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Sep 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.